Development of a digital pre-assessment pathway for patients starting systemic anticancer therapy
Intended for healthcare professionals
Evidence and practice    

Development of a digital pre-assessment pathway for patients starting systemic anticancer therapy

Amelia Weston SACT clinical nurse specialist, University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, England

Why you should read this article:
  • To understand the clinical reasons for pre-treatment assessment of patients undergoing systemic anticancer therapy (SACT)

  • To appreciate the benefits of a digital SACT pre-assessment pathway for cancer patients

  • To familiarise yourself with the challenges of providing a digital service

During the coronavirus disease 2019 (COVID-19) pandemic measures have been implemented in healthcare systems to reduce transmission of the infection. People with cancer are immunocompromised and at higher risk of contracting infections, therefore many cancer services have been conducting routine reviews and pre-treatment assessments remotely through telephone and video consultations during the pandemic. Patients who are to receive systemic anticancer therapy (SACT) should have an additional consultation to provide them with specific information about the therapy, including side effects and who to contact for advice if they develop these at home. This article describes the development and implementation of a digital SACT pre-assessment pathway in a large university hospital during the COVID-19 pandemic, which aimed to deliver information to groups of patients remotely. The article explores the challenges to implementation and discusses some of the findings of a patient feedback survey, which suggest that the digital SACT pre-assessment sessions have been successful overall.

Cancer Nursing Practice. doi: 10.7748/cnp.2022.e1814

Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

Correspondence

amelia.weston@uhs.nhs.uk

Conflict of interest

None declared

Weston A (2022) Development of a digital pre-assessment pathway for patients starting systemic anticancer therapy. Cancer Nursing Practice. doi: 10.7748/cnp.2022.e1814

Published online: 14 April 2022

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or